Published in
Elsevier, European Journal of Cancer, (75), p. 204-212
DOI: 10.1016/j.ejca.2017.01.019
Links
Tools
Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer
Journal article published in 2017 by
M. D. Franken,
E. M. van Rooijen,
A. M. May,
H. Koffijberg,
H. van Tinteren 
,
L. Mol,
A. J. ten Tije,
G. J. Creemers,
A. M. T. van der Velden,
B. C. Tanis,
C. A. Uyl-De Groot,
C. J. A. Punt,
M. Koopman,
M. G. H. van Oijen
,
L. Mol,
A. J. ten Tije,
G. J. Creemers,
A. M. T. van der Velden,
B. C. Tanis,
C. A. Uyl-De Groot,
C. J. A. Punt,
M. Koopman,
M. G. H. van Oijen
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 